Dalfampridine approved for MS.
Traynor
Kate
K
D015761:4-Aminopyridine / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D026902:Potassium Channel Blockers / Q000627:therapeutic use*
D026902:Potassium Channel Blockers; D015761:4-Aminopyridine